Randomized, Single Center Study About the Impact of an E-learning Dedicated to Myocardial Infarction Patient
1 other identifier
interventional
67
1 country
1
Brief Summary
Acute coronary syndrome (ACS) is still one of the major cause of morbi-mortality in Europe. After an ACS, patients should be treated with secondary prevention medication to reduce the risk of recurrence. However, it is known that patients do not take all their medicines as expected, which leads to readmission at the hospital. To enhance drug adherence, the investigators sought to develop an interactive e-learning tool for these patients. This e-learning includes information about the disease, the acute care and the subsequent medications being prescribed. The tool is now ready to use and the investigators want to assess if it has the impact to enhance self-care management of ACS patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 4, 2019
CompletedFirst Submitted
Initial submission to the registry
April 25, 2019
CompletedFirst Posted
Study publicly available on registry
May 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 22, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2020
CompletedSeptember 25, 2020
September 1, 2020
1.1 years
April 25, 2019
September 24, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ARMS (Adherence to Refill and Medication Score) score difference
Adherence to Refill and Medication Score is a self-reported questionnaire with 12-items. 8 items assess adherence to taking medications, and 4 items assess the refill to medication. The results can vary from 12 (most adherent) to 48 (less adherent). The ARMS questionnaire will be assessed after 1 month, 3 months and 6 months. We will assess the difference in the mean ARMS score between control group and intervention group at these 3 timepoints.
1,3 and 6 months
Secondary Outcomes (5)
Knowledge about the disease and medications
at time of inclusion, 1 day after inclusion for control group and after the viewing of the video for the intervention group, 1 month, 3 months and 6 months
LDL-c measurement
3 months
BMI
6 months
Target Blood Pressure
6 months
composite endpoint of readmission, reinfarction or emergency visit
6 months
Study Arms (2)
BASIC
EXPERIMENTAL"mon cœur, mon BASIC" video viewing and installation in the own smartphone or tablet of the patient
Control
NO INTERVENTIONUsual care
Interventions
The intervention consists of the presentation and installation of an internet tool to educate the patient about his heart condition and about his medications in addition to usual care. The tool is an interactive web-hosting video called "Mon Coeur, mon BASIC" adaptable to smartphones and tablets. The total length of the video is around 15 minutes. The e-learning is interactive because of the possibility to click in the video to have more details about a particular point. The tool includes a part about the heart and particularly about the ACS (physiopathology, diagnosis, coronarography, angioplasty). A second part includes an education about the medications prescribed. The patient will select the medication being prescribed and receive information about it.
Eligibility Criteria
You may qualify if:
- Admission for acute coronary syndrome (ACS) in the cardiology unit of the University hospital of Lausanne (NSTEMI or STEMI)
- Have a percutaneous coronary intervention (PCI) as therapeutic strategy
- Patients going through an elective PCI for a second vessel after having suffered from an acute coronary syndrome in the previous month
- \> 18 years
- Total discernment capacity and French speaking
- Have a digital tablet, a smartphone or a computer to have the possibility to watch the e-learning at home
- Informed Consent as documented by signature (Appendix Informed Consent Form)
You may not qualify if:
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
- Refugee claimants, homeless persons, prisoners by impossibility to contact them after discharge
- Patients with communication problems
- Life expectancy \< 6 months caused by other co-morbidities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hsopitalier Universitaire Vaudois
Lausanne, 1011, Switzerland
Related Publications (1)
Bruggmann C, Adjedj J, Sardy S, Muller O, Voirol P, Sadeghipour F. Effects of the Interactive Web-Based Video "Mon Coeur, Mon BASIC" on Drug Adherence of Patients With Myocardial Infarction: Randomized Controlled Trial. J Med Internet Res. 2021 Aug 30;23(8):e21938. doi: 10.2196/21938.
PMID: 34459744DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christel Bruggmann, PharmD
Centre Hospitalier Universitaire Vaudois (CHUV)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD student and clinical pharmacist
Study Record Dates
First Submitted
April 25, 2019
First Posted
May 14, 2019
Study Start
February 4, 2019
Primary Completion
March 22, 2020
Study Completion
July 15, 2020
Last Updated
September 25, 2020
Record last verified: 2020-09